Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - COST OF REVENUE
Cost of Revenue NBIX - Neurocrine Biosciences, Inc.
34 M
LAST VALUE
21.06%
2 YEAR CAGR
35.66%
5 YEAR CAGR
8.97%
10 YEAR CAGR